Correlation of UCH-L1 and GFAP in predicting severity of traumatic brain injury in an Asian population

Submitted: 1 July 2024
Accepted: 7 November 2024
Published: 20 December 2024
Abstract Views: 249
PDF: 75
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The application of biomarkers in TBI management remains underutilised with paucity of data in Asian populations. This study investigated the correlation between UCH-L1 and GFAP with TBI severity and patient outcomes in a Malaysian tertiary centre. The study was conducted at Universiti Malaya Medical Centre in Kuala Lumpur, Malaysia, from February 1, 2017, to November 30, 2019. GFAP and UCH-L1 were measured in 61 TBI cases and 19 controls. Correlations between biomarkers and TBI severity, as well as patient outcomes, were assessed using Spearman's rank correlation coefficient. GFAP/UCHL1 showed significant correlation with Marshall CT classification (r=0.437, p<0.001), Glasgow Coma Scale on arrival (r=-0.444, p<0.001), and Acute Physiology and Chronic Health Evaluation II (APACHEII) score (r=0.501, p<0.001). GFAP demonstrated fair-to-good accuracy in predicting TBI severity and outcomes. A consistent cut-off value of 0.01845 ng/mL for GFAP and 0.01960 for GFAP/UCHL1 predicted TBI severity, with high sensitivity (72.2-100%) and acceptable specificity (38.8-80.0%). GFAP and GFAP/UCHL1 showed promising utility in predicting TBI severity and patient outcomes in the Asian population. The findings underscore the potential clinical significance of biomarker assessment in TBI management, though further validation in larger cohorts is warranted.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Guan B, Anderson DB, Chen L, et al. Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. BMJ Open 2023;13:e075049. DOI: https://doi.org/10.1136/bmjopen-2023-075049
McCrea MA, Giacino JT, Barber J, et al. Functional outcomes over the first year after moderate to severe traumatic brain injury in the prospective, longitudinal TRACK-TBI Study. JAMA Neurol 2021;78:982-92. DOI: https://doi.org/10.1001/jamaneurol.2021.2043
Reith FC, Van den Brande R, Synnot A, et al. The reliability of the Glasgow Coma Scale: a systematic review. Intensive Care Med 2016;42:3-15. DOI: https://doi.org/10.1007/s00134-015-4124-3
Sherer M, Struchen MA, Yablon SA, et al. Comparison of indices of traumatic brain injury severity: Glasgow Coma Scale, length of coma and post-traumatic amnesia. J Neurol Neurosurg Psychiatr 2008;79:678-85. DOI: https://doi.org/10.1136/jnnp.2006.111187
Wang KK, Yang Z, Zhu T, et al. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Molec Diagnost 2018;18:165-80. DOI: https://doi.org/10.1080/14737159.2018.1428089
Wilde EA, Wanner I-B, Kenney K, et al. A framework to advance biomarker development in the diagnosis, outcome prediction, and treatment of traumatic brain injury. J Neurotrauma 2022;39:436-57. DOI: https://doi.org/10.1089/neu.2021.0099
Helmrich IRR, Czeiter E, Amrein K, et al. Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study. Lancet Neurol 2022;21:792-802. DOI: https://doi.org/10.1016/S1474-4422(22)00218-6
Papa L, Lewis LM, Falk JL, et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med 2012;59:471-83. DOI: https://doi.org/10.1016/j.annemergmed.2011.08.021
Association for the Advancement of Automotive Medicine. Abbreviated Injury Scale: 2015 Revision (6 ed.). 6 ed. Chicago, IL 2018.
Marshall LF, Marshall SB, Klauber MR, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 1992;9:S287-S92.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Med 1985;13:818-29. DOI: https://doi.org/10.1097/00003246-198510000-00009
Vos PE, Lamers K, Hendriks J, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-10. DOI: https://doi.org/10.1212/01.WNL.0000120550.00643.DC
Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670-5. DOI: https://doi.org/10.1093/aje/kwj063
Obuchowski NA. Receiver operating characteristic curves and their use in radiology. Radiology 2003;229:3-8. DOI: https://doi.org/10.1148/radiol.2291010898
Mondello S, Jeromin A, Buki A, et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma 2012;29:1096-104. DOI: https://doi.org/10.1089/neu.2011.2092
Mondello S, Papa L, Buki A, et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care 2011;15:R156. DOI: https://doi.org/10.1186/cc10286
Wang KKW, Kobeissy FH, Shakkour Z, Tyndall JA. Thorough overview of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury. Acute Med Surg 2021;8:e622. DOI: https://doi.org/10.1002/ams2.622
Diaz-Arrastia R, Wang KK, Papa L, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 2014;31:19-25. DOI: https://doi.org/10.1089/neu.2013.3040
Mondello S, Linnet A, Buki A, et al. Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 2012;70:666-75.
Papa L, Lewis LM, Silvestri S, et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J Trauma Acute Care Surg 2012;72:1335-44. DOI: https://doi.org/10.1097/TA.0b013e3182491e3d
Papa L, Silvestri S, Brophy GM, et al. GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotrauma 2014;31:1815-22. DOI: https://doi.org/10.1089/neu.2013.3245
Takala RSK, Posti JP, Runtti H, et al. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury. World Neurosurgery 2016;87:8-20. DOI: https://doi.org/10.1016/j.wneu.2015.10.066

How to Cite

Poh, K., Poh Yuen Ying, R., Mohd Noor, S., Bustam, A., Norazit, A., Zambri, A., & Noor Azhar, M. (2024). Correlation of UCH-L1 and GFAP in predicting severity of traumatic brain injury in an Asian population. Emergency Care Journal. https://doi.org/10.4081/ecj.2024.12764